BreastAntineoplastic AgentsRadiation DosageRadiation, IonizingRadiation InjuriesCell Line, TumorCarcinoma, Ductal, BreastDose-Response Relationship, RadiationRadiation ToleranceBreast DiseasesRadiationDrug Screening Assays, AntitumorRadiation ProtectionNeoplasmsRadiation MonitoringApoptosisDrug Resistance, NeoplasmDoxorubicinBreast FeedingTumor Cells, CulturedAntineoplastic Agents, PhytogenicRadiation OncologyAntibiotics, AntineoplasticCell SurvivalMice, NudeGene Expression Regulation, NeoplasticCisplatinCell ProliferationXenograft Model Antitumor AssaysDrug Delivery SystemsCosmic RadiationGamma RaysReceptors, EstrogenBreast Neoplasms, MaleRadiation Injuries, ExperimentalDNA DamageRadiotherapyNeoplasms, Radiation-InducedRadiation PneumonitisMammographyDrug CarriersReceptor, erbB-2Radiation-Sensitizing AgentsFibrocystic Breast DiseaseTime FactorsBackground RadiationEllipticinesNeoplasm ProteinsDose-Response Relationship, DrugTamoxifenRadiotherapy DosageMCF-7 CellsBreast ImplantsCell CycleUltraviolet RaysRadiometryEtoposideDrug Resistance, MultipleP-GlycoproteinTumor Markers, BiologicalInhibitory Concentration 50Antineoplastic Combined Chemotherapy ProtocolsCamptothecinPrognosisReceptors, ProgesteroneFluorouracilBreast Self-ExaminationNeoplasm MetastasisDrug SynergismPaclitaxelCombined Modality TherapyMolecular StructureSignal TransductionNeoplasm InvasivenessMastectomyTumor Suppressor Protein p53Radiation EffectsNeoplasm StagingTreatment OutcomeNeoplasm TransplantationDrug DesignCell DivisionCarcinomaEnzyme InhibitorsImmunohistochemistryCarcinoma, Intraductal, NoninfiltratingBreast NeoplasmsDNA Topoisomerases, Type IIBlotting, WesternRadiation-Protective AgentsDNA RepairRNA, MessengerProdrugsTransplantation, HeterologousMammary Neoplasms, ExperimentalRisk FactorsAdenocarcinomaCarcinoma, LobularPlant ExtractsMastectomy, Segmental